Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Summary by PR Newswire
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the...

40 Articles

Bennington BannerBennington Banner
+37 Reposted by 37 other sources
Center

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

$12.5 million in gross financings raised during the quarter, with an additional $9 million raised by Citius Oncology in July 2025, to facilitate LYMPHIR pre-launch initiatives and drive successful market introduction

Read Full Article
Financial PostFinancial Post
Lean Right

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026 Announced positive dat…

·Canada
Read Full Article
Voice of AlexandriaVoice of Alexandria

DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

MINNEAPOLIS--(BUSINESS WIRE)--Aug 12, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources are Center, 40% of the sources lean Right
40% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Voice of Alexandria broke the news in on Tuesday, August 12, 2025.
Sources are mostly out of (0)

Similar News Topics

Business icon

Business

Bennington icon

Bennington

News
For You
SearchBlindspotLocal